1. Therapeutic Use of Botulinum Toxin Type A in Treating Neck and Upper-Back Pain of Myofascial Origin: A Pilot Study 
Henry L. Lew, MD, PhD, Eun Ha Lee, MD, PhD, Annabel Castaneda, MD, MPH, Roger Klima, MD, Elaine Date, MD 
Archives of Physical Medicine and Rehabilitation 
Volume 89, Issue 1, Pages (January 2008)
DOI: /j.apmr
Copyright © 2008 American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation Terms and Conditions

2. Fig 1 Flow of participants in the study.
Archives of Physical Medicine and Rehabilitation  , 75-80DOI: ( /j.apmr )
Copyright © 2008 American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation Terms and Conditions

3. Fig 2
Mean changes in pain scores on the VAS from baseline (BTX-A vs control). Negative change indicates improved outcome.
Archives of Physical Medicine and Rehabilitation  , 75-80DOI: ( /j.apmr )
Copyright © 2008 American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation Terms and Conditions

4. Fig 3
Improvement in mean scores on the SF-36 bodily pain scale from baseline (BTX-A vs control). *Statistically significantly better outcome for the BTX-A group (P<.025).
Archives of Physical Medicine and Rehabilitation  , 75-80DOI: ( /j.apmr )
Copyright © 2008 American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation Terms and Conditions

5. Fig 4
Improvement in mean scores on the SF-36 mental health scale from baseline (BTX-A vs control). *Statistically significantly better outcome for the BTX-A group (P<.025).
Archives of Physical Medicine and Rehabilitation  , 75-80DOI: ( /j.apmr )
Copyright © 2008 American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation Terms and Conditions